Lifevantage (LFVN) EBIT (2010 - 2026)

Lifevantage has reported EBIT for 17 years, with the latest figure at $1.7 million in Q1 2026.

• For the quarter ending Q1 2026, EBIT fell 58.6% year-over-year to $1.7 million; the trailing twelve-month figure through Mar 2026 stood at $6.6 million (down 49.22% YoY), and the FY2025 full-year result was $12.2 million, up 181.6% from the prior year.
• EBIT for Q1 2026 stood at $1.7 million, up from $487000.0 in the prior quarter.
• The five-year high for EBIT was $4.1 million in Q1 2025, with the low at -$1.3 million in Q4 2023.
• Historically, EBIT has averaged $1.7 million across 5 years, with a median of $1.8 million in 2022.
• Annual changes were most pronounced in 2022 — EBIT tumbled 244.13% — and 2024, when it surged 371.85%.
• Lifevantage's EBIT stood at -$1.2 million in 2022, then dropped by 2.35% to -$1.3 million in 2023, then surged by 371.85% to $3.4 million in 2024, then tumbled by 85.79% to $487000.0 in 2025, then jumped by 244.56% to $1.7 million in 2026.
• The last three EBIT figures came in at $1.7 million (Q1 2026), $487000.0 (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.